MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Maxillary sinus augmentation remains a cornerstone intervention for addressing insufficient bone height in the posterior maxilla prior to dental implant placement. Techniques such as the lateral ...
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced ...
Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...
CMS Approves SINUVA® Sinus Implant for Reimbursement with New C-Code and Pass-Through Payment Status
MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that the Centers ...
Elk Grove's Ora Dental Implant Studio Recognized as 2026 Top Patient Rated Provider by Find Local Doctors The AAAHC-accredited implant specialty practice combines a tranquil, spa-like atmosphere with ...
DrBicuspid.com is pleased to present the next column from two lawyers who spend every day defending dentists in litigation and before the licensing board. The purpose of this column is to offer our ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
BOSTON (CBS) - Chronic sinusitis is one of the most common reasons people head to the doctor. Mild cases can be treated with antibiotics, but more severe cases may require surgery. In the past, many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback